A cause of this heterogeneity may be that several signaling factors known to influence angio-proliferative function of ECFC, i.e., IL-6, IL1b, PDGF-b, and TNF-α [28], are highly upregulated in PAH. The gene discussed is IL6; the disease is pulmonary arterial hypertension.